Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 2
1986 1
1988 1
1989 1
1990 1
1991 2
1992 2
1994 1
1998 1
1999 3
2000 3
2001 3
2002 3
2003 4
2004 2
2005 2
2006 3
2007 2
2008 1
2009 3
2010 2
2011 5
2012 10
2013 10
2014 11
2015 12
2016 15
2017 14
2018 15
2019 16
2020 19
2021 29
2022 28
2023 30
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Belumosudil: First Approval.
Blair HA. Blair HA. Drugs. 2021 Sep;81(14):1677-1682. doi: 10.1007/s40265-021-01593-z. Drugs. 2021. PMID: 34463931 Free PMC article. Review.
In July 2021, belumosudil received its first approval in the USA for the treatment of adult and paediatric patients aged 12 years with cGVHD after failure of at least two prior lines of systemic therapy. Belumosudil is under regulatory review in Australia, Canada, the UK a …
In July 2021, belumosudil received its first approval in the USA for the treatment of adult and paediatric patients aged 12 years with cGVHD …
Sotorasib: First Approval.
Blair HA. Blair HA. Drugs. 2021 Sep;81(13):1573-1579. doi: 10.1007/s40265-021-01574-2. Drugs. 2021. PMID: 34357500 Free PMC article. Review.
In May 2021, sotorasib was granted accelerated approval by the US FDA for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic NSCLC, as determined by an FDA-approved test, who have received at least one prior systemic therapy. This article …
In May 2021, sotorasib was granted accelerated approval by the US FDA for the treatment of adult patients with KRAS G12C-mutated locally adv …
Neoadjuvant Enzalutamide Prior to Prostatectomy.
Montgomery B, Tretiakova MS, Joshua AM, Gleave ME, Fleshner N, Bubley GJ, Mostaghel EA, Chi KN, Lin DW, Sanda M, Novotny W, Wu K, Kantoff PW, Marck BT, Plymate S, Balk SP, Nelson PS, Matsumoto AM, Lis RT, Kibel A, Haas GP, Krivoshik A, Hannah A, Taplin ME. Montgomery B, et al. Clin Cancer Res. 2017 May 1;23(9):2169-2176. doi: 10.1158/1078-0432.CCR-16-1357. Epub 2016 Nov 9. Clin Cancer Res. 2017. PMID: 28151719 Free PMC article. Clinical Trial.
Optimal AR antagonism may effectively cytoreduce local disease and suppress or eliminate micrometastases. We evaluated neoadjuvant therapy prior to prostatectomy with the potent AR antagonist enzalutamide (enza) either alone or in combination with dutasteride (dut) and leu …
Optimal AR antagonism may effectively cytoreduce local disease and suppress or eliminate micrometastases. We evaluated neoadjuvant therapy …
End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study.
van Dissel AC, Opotowsky AR, Burchill LJ, Aboulhosn J, Grewal J, Lubert AM, Antonova P, Shah S, Cotts T, John AS, Kay WA, DeZorzi C, Magalski A, Han F, Baker D, Kay J, Yeung E, Vonder Muhll I, Pylypchuk S, Kuo MC, Nicolarsen J, Sarubbi B, Fusco F, Jameson SM, Cramer J, Gupta T, Gallego P, O'Donnell C, Hannah J, Dellborg M, Kauling RM, Ginde S, Krieger EV, Rodriguez F, Dehghani P, Kutty S, Wong J, Wilson WM, Rodriguez-Monserrate CP, Roos-Hesselink J, Celermajer DS, Khairy P, Broberg CS. van Dissel AC, et al. Eur Heart J. 2023 Sep 7;44(34):3278-3291. doi: 10.1093/eurheartj/ehad511. Eur Heart J. 2023. PMID: 37592821 Free PMC article.
Individuals who underwent childhood surgery had more adverse outcomes than age- and sex-matched controls. Multivariable Cox regression analysis identified older age, prior CHF admission, and severe RV dysfunction as independent predictors for the primary outcome. ...
Individuals who underwent childhood surgery had more adverse outcomes than age- and sex-matched controls. Multivariable Cox regression analy …
Biological Drivers of Wilms Tumor Prognosis and Treatment.
Phelps HM, Kaviany S, Borinstein SC, Lovvorn HN 3rd. Phelps HM, et al. Children (Basel). 2018 Oct 26;5(11):145. doi: 10.3390/children5110145. Children (Basel). 2018. PMID: 30373137 Free PMC article. Review.
Prior to the 1950s, survival from Wilms tumor (WT) was less than 10%. ...
Prior to the 1950s, survival from Wilms tumor (WT) was less than 10%. ...
Fibre-rich diet attenuates chemotherapy-related neuroinflammation in mice.
Cross C, Davies M, Bateman E, Crame E, Joyce P, Wignall A, Ariaee A, Gladman MA, Wardill H, Bowen J. Cross C, et al. Brain Behav Immun. 2024 Jan;115:13-25. doi: 10.1016/j.bbi.2023.09.018. Epub 2023 Sep 25. Brain Behav Immun. 2024. PMID: 37757978 Free article.
Twenty-four female C57Bl/6 mice were treated with 5-FU (400 mg/kg, intraperitoneal, i.p.) or vehicle control, with or without a high fibre diet (constituting amylose starch; 4.7 % crude fibre content), given one week prior to 5-FU and until study completion (16 days after …
Twenty-four female C57Bl/6 mice were treated with 5-FU (400 mg/kg, intraperitoneal, i.p.) or vehicle control, with or without a high fibre d …
Maintenance of sexual activity following androgen deprivation in males.
Duthie CJ, Calich HJ, Rapsey CM, Wibowo E. Duthie CJ, et al. Crit Rev Oncol Hematol. 2020 Sep;153:103064. doi: 10.1016/j.critrevonc.2020.103064. Epub 2020 Jul 15. Crit Rev Oncol Hematol. 2020. PMID: 32712517 Review.
Here, we use a biopsychosocial framework to review factors that may influence the ability of patients on ADT to remain sexually active. We address sexual factors prior to ADT, neurobiological factors, intermittent ADT, sex aids, exercise, sleep, partner factors, masculinit …
Here, we use a biopsychosocial framework to review factors that may influence the ability of patients on ADT to remain sexually active. We a …
The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness.
Dennis M, Sandercock P, Graham C, Forbes J; CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration; Smith J. Dennis M, et al. Health Technol Assess. 2015 Sep;19(76):1-90. doi: 10.3310/hta19760. Health Technol Assess. 2015. PMID: 26418530 Free PMC article. Clinical Trial.
The primary outcome occurred in 122 (8.5%) of 1438 patients allocated to IPC and 174 (12.1%) of 1438 patients allocated to no IPC, giving an absolute reduction in risk of 3.6% [95% confidence interval (CI) 1.4% to 5.8%] and a relative risk reduction of 0.69 (95% CI 0.55 to 0.86). …
The primary outcome occurred in 122 (8.5%) of 1438 patients allocated to IPC and 174 (12.1%) of 1438 patients allocated to no IPC, giving an …
Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma.
France NL, Blair HA. France NL, et al. Target Oncol. 2024 Jan;19(1):115-123. doi: 10.1007/s11523-023-01026-9. Epub 2024 Jan 18. Target Oncol. 2024. PMID: 38236364 Free PMC article. Review.
In the phase III HIMALAYA trial, STRIDE significantly improved overall survival (OS) compared with sorafenib in adults with unresectable HCC and no prior systemic therapy. A higher proportion of STRIDE versus sorafenib recipients had an objective response to treatment. ...
In the phase III HIMALAYA trial, STRIDE significantly improved overall survival (OS) compared with sorafenib in adults with unresectable HCC …
Pre-operative carbohydrate loading prior to elective caesarean delivery: a randomised controlled trial.
Clark A, Litchfield K, Hannah S, Love C, Slade K, Lake K, Agaram R. Clark A, et al. Int J Obstet Anesth. 2021 Feb;45:21-27. doi: 10.1016/j.ijoa.2020.10.008. Epub 2020 Oct 18. Int J Obstet Anesth. 2021. PMID: 33277162 Clinical Trial.
INTRODUCTION: Women undergoing elective caesarean deliveries are fasted for long periods prior to surgery and can become catabolic. The use of pre-operative carbohydrate drinks to optimise patients ahead of major surgery is now well established. ...METHODS: We conducted a …
INTRODUCTION: Women undergoing elective caesarean deliveries are fasted for long periods prior to surgery and can become catabolic. T …
236 results